Understanding how cannabidiol (CBD) exerts its myriad effects on human physiology is a work in progress. Thus far, scientists have identified more than 60 different molecular pathways through which CBD operates. It is known, for example, that CBD acts through multiple receptor-independent channels and it also binds to various receptors in the brain, including serotonin 5HT1A (which contributes to CBD’s antidepressant effect), TRPV1 (which contributes to CBD’s anti-psychotic effect), the nuclear receptor PPAR-gamma (regulates gene expression), and the orphan receptor GPR55, among others.
Professor Greg Gerdeman on brain science, the neurobiology of stress, and how the discovery of the endocannabinoid system has liberated cannabis from the drug abuse paradigm. Here is a wonderful interview with Professor Gerdeman with Project CBD:
In order for the cannabis industry to join the ranks of the 21stCentury consumer marketplace, quality control that establishes consistency and accuracy in analyzing cannabis is key. Here are four reasons why.
1. For the safety and satisfaction of the consumer: Cannabis consumers deserve to know exactly how potent their cannabis is when they purchase it. Getting the dosage and ratios of THC to CBD just right is important for medical marijuana patients in particular who are Continue reading
Sage Analytics (www.sageanalytics.com), the developers of a new generation of laboratory-quality cannabis potency measurement systems, announced today the completion of their data collection and final application modeling of a highly anticipated, advanced cannabis potency testing system.
The Luminary™ Profiler and the Luminary™ Beacon incorporate Sage Analytics’ proprietary predictive models, which were developed in conjunction with premier laboratories as well as the university that is Continue reading